Fatty acid synthase and cancer: new application of an old pathway - PubMed (original) (raw)

Review

Fatty acid synthase and cancer: new application of an old pathway

Francis P Kuhajda. Cancer Res. 2006.

Abstract

Fatty acid synthase (FAS), the sole mammalian enzyme capable of de novo fatty acid synthesis, is highly expressed in most human carcinomas. FAS is associated with poor prognosis in breast and prostate cancer, is elaborated into the blood of cancer patients, and its inhibition is selectively cytotoxic to human cancer cells. Thus, FAS and fatty acid metabolism in cancer has become a focus for the potential diagnosis and treatment of cancer.

PubMed Disclaimer

Similar articles

• Fatty acid synthase: a metabolic oncogene in prostate cancer?
  Baron A, Migita T, Tang D, Loda M. Baron A, et al. J Cell Biochem. 2004 Jan 1;91(1):47-53. doi: 10.1002/jcb.10708. J Cell Biochem. 2004. PMID: 14689581 Review.
• [Fatty acid synthase and prostate cancer].
  Wang KF, Wu B. Wang KF, et al. Zhonghua Nan Ke Xue. 2008 Aug;14(8):740-2. Zhonghua Nan Ke Xue. 2008. PMID: 18817351 Review. Chinese.
• Fatty acid synthase-catalyzed de novo fatty acid biosynthesis: from anabolic-energy-storage pathway in normal tissues to jack-of-all-trades in cancer cells.
  Menendez JA, Lupu R. Menendez JA, et al. Arch Immunol Ther Exp (Warsz). 2004 Nov-Dec;52(6):414-26. Arch Immunol Ther Exp (Warsz). 2004. PMID: 15577743 Review.
• Fatty acid synthase inhibition activates AMP-activated protein kinase in SKOV3 human ovarian cancer cells.
  Zhou W, Han WF, Landree LE, Thupari JN, Pinn ML, Bililign T, Kim EK, Vadlamudi A, Medghalchi SM, El Meskini R, Ronnett GV, Townsend CA, Kuhajda FP. Zhou W, et al. Cancer Res. 2007 Apr 1;67(7):2964-71. doi: 10.1158/0008-5472.CAN-06-3439. Cancer Res. 2007. PMID: 17409402
• Enzymes of the fatty acid synthesis pathway are highly expressed in in situ breast carcinoma.
  Milgraum LZ, Witters LA, Pasternack GR, Kuhajda FP. Milgraum LZ, et al. Clin Cancer Res. 1997 Nov;3(11):2115-20. Clin Cancer Res. 1997. PMID: 9815604

Cited by

• Role of FGF21 in mediating the effect of phosphatidylcholine on GBM.
  Wang P, Zhang X, Xiao B, Ouyang J, Zhang J, Peng X. Wang P, et al. Front Oncol. 2024 Sep 2;14:1428025. doi: 10.3389/fonc.2024.1428025. eCollection 2024. Front Oncol. 2024. PMID: 39286013 Free PMC article.
• Characteristics, clinical significance, and cancer immune interactions of lipid metabolism in prostate cancer.
  Xu Z, Xu X, Hu J, Tan J, Wan Y, Cui F. Xu Z, et al. Transl Cancer Res. 2024 Jul 31;13(7):3575-3588. doi: 10.21037/tcr-23-2140. Epub 2024 Jul 26. Transl Cancer Res. 2024. PMID: 39145061 Free PMC article.
• Fatty Acid Synthase Promotes Hepatocellular Carcinoma Growth via S-Phase Kinase-Associated Protein 2/p27KIP1 Regulation.
  Cigliano A, Simile MM, Vidili G, Pes GM, Dore MP, Urigo F, Cossu E, Che L, Feo C, Steinmann SM, Ribback S, Pascale RM, Evert M, Chen X, Calvisi DF. Cigliano A, et al. Medicina (Kaunas). 2024 Jul 18;60(7):1160. doi: 10.3390/medicina60071160. Medicina (Kaunas). 2024. PMID: 39064589 Free PMC article.
• Ficolin 3 promotes ferroptosis in HCC by downregulating IR/SREBP axis-mediated MUFA synthesis.
  Yuan Y, Xu J, Jiang Q, Yang C, Wang N, Liu X, Piao HL, Lu S, Zhang X, Han L, Liu Z, Cai J, Liu F, Chen S, Liu J. Yuan Y, et al. J Exp Clin Cancer Res. 2024 May 3;43(1):133. doi: 10.1186/s13046-024-03047-2. J Exp Clin Cancer Res. 2024. PMID: 38698462 Free PMC article.
• The Lipidomic Signature of Glioblastoma: A Promising Frontier in Cancer Research.
  Yu N, Aboud O. Yu N, et al. Cancers (Basel). 2024 Mar 8;16(6):1089. doi: 10.3390/cancers16061089. Cancers (Basel). 2024. PMID: 38539424 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Silverchair Information Systems

• Other Literature Sources

  • The Lens - Patent Citations

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal